HTG Molecular Diagnostics Reports Third Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Survey Shows Low Awareness and Purchase Intent on HTG Molecular Diagnostics (HTGM); Leerink Partners Cuts Price Target to $10
November 13, 2015 10:12 AM ESTLeerink Partners reiterates an Outperform rating on HTG Molecular Diagnostics (NASDAQ: HTGM), and cut the price target to $10.00 (from $18.00), following the company's 3Q15 earnings report. HTGM reported Q3 revenue of $1M, in line with the Street expectation. However, Survey work suggests awareness of its... More
HTG Molecular Diagnostics (HTGM) Tops Q3 EPS by 9c
November 12, 2015 4:42 PM ESTHTG Molecular Diagnostics (NASDAQ: HTGM) reported Q3 EPS of ($0.76), $0.09 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.07 million.
For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.
... More


